Therapeutic Antibodies for the Treatment of Respiratory Tract Infections—Current Overview and Perspectives

Therapeutic Antibodies for the Treatment of Respiratory Tract Infections—Current Overview and Perspectives

Respiratorytract infections (RTIs) are frequent and life-threatening diseases, accounting for several millions of deaths worldwide. RTIs implicate microorganisms, including viruses (influenza virus, coronavirus, respiratory syncytial virus (RSV)), bacteria (<i>Pseudomonas aeruginosa</i>,...

Full description

Bibliographic Details
Main Authors: Alexie Mayor, Adélaïde Chesnay, Guillaume Desoubeaux, David Ternant, Nathalie Heuzé-Vourc’h, Thomas Sécher
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Vaccines
Subjects:
therapeutic antibodies
respiratory tract infection
pharmacodynamics (PD)
pharmacokinetics (PK)
clinical development
Online Access:https://www.mdpi.com/2076-393X/9/2/151

Internet

https://www.mdpi.com/2076-393X/9/2/151

Similar Items